Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)

NCT05974839 · clinicaltrials.gov ↗

COMPLETED

Status

732

Enrollment

OTHER

Sponsor class

Conditions

Primary Progressive Multiple Sclerosis

Interventions

OTHER: Ocrelizumab

Sponsor

State University of New York at Buffalo

Collaborators

[object Object]